Efficacy Study of Omega Onychocryptosis Correction in the Treatment of Mild to Moderate Onychocryptosis

Abstract

Objective: To investigate the effectiveness of Omega in the correction of onychocryptosis among individuals with mild to moderate cases. Methods: Sixty patients with mild to moderate onychocryptosis, treated at our institution from April 1, 2023, to March 31, 2025, were selected as subjects for this study. The participants were randomly assigned into two groups using a random number table: the control group, which received nail groove packing, and the observation group, which underwent Omega onychocryptosis correction, with 30 patients in each group. The relief from inflammation, duration of healing, comfort of the foot, and satisfaction levels of the two groups were assessed and compared. Results: The duration of redness and swelling, discomfort, exudate, and healing time in the observation group were all significantly shorter than in the control group (P < 0.05). No significant difference in VAS scores was seen between the two groups three days post-treatment (P > 0.05); however, one and two weeks post-treatment, the VAS scores in the observation group were significantly lower than those in the control group (P < 0.05). The observation group’s satisfaction rating was 100.00% (30/30), markedly surpassing the control group’s rate of 83.33% (25/30), with statistical significance (P < 0.05). Conclusion: Omega onychocryptosis correction for individuals with mild to moderate onychocryptosis can yield favorable treatment outcomes, significantly alleviate pain, enhance symptomatology, and elevate patient satisfaction.